Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias

Archives of Gynecology and Obstetrics

Volumn 284, Issue 1, 2011, Pages 209-214

  Abike, Faruk ^a   Engin, Ayse Basak ^b   Dunder, Ilkkan ^c   Tapisiz, Omer Lutfi ^d   Aslan, Canan ^c   Kutluay, Lale ^a  

^a BAYINDIR HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ISTANBUL BILIM UNIVERSITY   (Turkey)

^d Dr Zekai Tahir Burak Women Health Education and Research Hospital   (Turkey)

Author keywords

Cervical dysplasia; Folate; Homocysteine; HPV infection; Neopterin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NEOPTERIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ATYPICAL SQUAMOUS CELL UNDETERMINED SIGNIFICANCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN CELL; HUMAN TISSUE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PROTEIN BLOOD LEVEL; SQUAMOUS EPITHELIUM; TUMOR GROWTH; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX DYSPLASIA; VITAMIN BLOOD LEVEL; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLIC ACID; HOMOCYSTEINE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; NEOPTERIN; UTERINE CERVICAL NEOPLASMS;

EID: 79958778354     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1650-7     Document Type: Article

References (33)

1. Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon
2. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4-S66
3. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N et al (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181:1911-1919 (Pubitemid 30416152)
4. Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265 (Pubitemid 34293391)
5. Chew GK, Cruickshank ME, Rooney PH, Miller ID, Parkin DE, Murray GI (2005) Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 93:1301-1304 (Pubitemid 41679417)
6. (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papilloma viruses. International Agency for Research on Cancer, Lyon
7. Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127(8):930-934 (Pubitemid 36994850)
8. ASCUS-LSIL Traige Study (ALTS) Group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188(6):1393-1400
9. Whitehead N, Reyner F, Lindenbaum J (1973) Megaloblastic changes in the cervical epithelium. J Am Med Assoc 226:1421-1424
10. Butterworth CE (1992) Effect of folate on cervical cancer. Ann N Y Acad Sci 669:293-299
11. Mason JB, Levesque T (1996) Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Basel) 10:1727-1742
12. Weir DG, Scott JM (1999) Cobalamins: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 394-401
13. McPartlin J, Weir DG, Scott JM (1999) Folic acid: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 803-811
14. Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis and the homocysteine-folate-cobalamin triad: do we need standardized analyses? J Am Coll Nutr 16:258-267
15. Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid, total homocysteine determinations for diagnosing cobalamin, folate deficiencies. Am J Med 96(3):239-246 (Pubitemid 24099223)
16. Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD (2001) Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12(4):317-324 (Pubitemid 32553624)
17. Kwaśniewska A, Tukendorf A, Goździcka-Józefiak A, Semczuk-Sikora A, Korobowicz E (2002) Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 23(4):311-316 (Pubitemid 34948046)
18. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss C, Werner R, Werner-Febmayer C (1992) Neopterin: biochemistry, methods, clinical applications. Walter de Gruyter, New York
19. Reibnegger CJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzeb HM, Lutz H, Werner ER, Wachter H (1986) Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 46:950-955 (Pubitemid 16145461)
20. Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3-4):307-341 (Pubitemid 23011151)
21. Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA (2007) C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107(1):114-117 (Pubitemid 47464551)
22. Yamada N, Nakayama A, Kubota K, Kawakami A, Suzuki E (2008) Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 56(5):409-415
23. Chandra S, Chandra RK (1986) Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1-65 (Pubitemid 17031091)
24. Dhur A, Galan P, Hercberg S (1991) Folate status and the immune system. Prog Food Nutr Sci 15:43-60
25. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187-195 (Pubitemid 26036914)
26. Popescu NC, DiPaolo JA, Amsbaugh SC (1987) Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44:58-62 (Pubitemid 17037174)
27. Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D (2003) Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 17:A373
28. Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC et al (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788-8793 (Pubitemid 39552099)
29. Piyathilake CJ, Macaluso M, Brill I, Heimburger DC, Partridge EE (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23(3):203-210 (Pubitemid 46367566)
30. Kwaśniewska A, Tukendorf A, Semczuk M (1997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18(6):526-530 (Pubitemid 27519427)
31. Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64(23):8788-8793 (Pubitemid 39552099)
32. Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45(1):47-53 (Pubitemid 46155559)
33. Oner N, Vatansever U, Karasalihoǧlu S, Ekuklu G, Celtik C, Biner B (2006) The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc Health 38(5):599-606